Common Equity: The sum of all common equity items.
Avadel Pharmaceuticals PLC. (AVDL) had Common Equity of $73.85M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$50.41M |
|
$-5.04M |
|
$4.81M |
|
$45.60M |
|
$53.71M |
|
$-3.30M |
|
$-1.67M |
|
$-4.96M |
|
$-4.96M |
|
$-5.04M |
|
$-5.04M |
|
$-5.04M |
|
$-5.04M |
|
$-3.30M |
|
$-2.63M |
|
95.14M |
|
95.14M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$134.21M |
|
$0.45M |
|
$30.03M |
|
$164.24M |
|
$48.83M |
|
-- |
|
$41.55M |
|
$90.39M |
|
|
Common Equity |
$73.85M |
$57.01M |
|
$73.85M |
|
96.52M |
|
| Cash Flow Statement Financials | |
$-46.91M |
|
$51.78M |
|
$15.97M |
|
$31.17M |
|
$51.37M |
|
$20.20M |
|
$20.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.45% |
|
-6.54% |
|
-6.54% |
|
-- |
|
-9.84% |
|
-10.00% |
|
$-46.91M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
0.24 |
|
1.48 |
|
60.88 |
|
-6.83% |
|
-8.85% |
|
-3.07% |
|
-6.83% |
|
$0.77 |
|
$-0.49 |
|
$-0.49 |
|